A Promethean Construct: Formulation of a bioink with human donor-derived liver dECM & liver organoids

Liver diseases account for two million deaths worldwide each year, and current treatments are limited. 3D bioprinting is a promising technology, that has recently been investigated to tackle this challenge. However, the cells and hydrogels used for bioprinting are not human-derived and do not replicate the natural <i>in vivo</i> environment. The...